Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy

Author(s):

Anna C. Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, Brendan L. Harney, Irene Boo, Long Nguyen, Damian Pavlyshyn, Paul M. Dietze, Heidi E. Drummer, Alexander J. Thompson, Anthony Jaworowski, Margaret E. Hellard, Rachel Sacks-Davis, Joseph S. Doyle

Details:

Frontiers in Immunology, Volume 15, 2024-01-01, Article number 1352440

Article Link: Click here

Affiliations:

• Monash University
• Melbourne School of Population and Global Health
• The Peter Doherty Institute for Infection and Immunity
• University of Melbourne
• The National Drug Research Institute
• Burnet Institute